These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 24708392

  • 1. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP, Pierce M, O'Neill C, Foster S, Jennings C.
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [Abstract] [Full Text] [Related]

  • 2. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
    Schulman EA.
    Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
    [Abstract] [Full Text] [Related]

  • 3. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Vikelis M, Mitsikostas DD, Rapoport AM.
    Pain Manag; 2014 Mar; 4(2):123-8. PubMed ID: 24641436
    [Abstract] [Full Text] [Related]

  • 4. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 5. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
    Pierce M, O'Neill C, Felker E, Sebree T.
    Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
    [Abstract] [Full Text] [Related]

  • 6. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
    Smith TR, Goldstein J, Singer R, Pugach N, Silberstein S, Pierce MW.
    Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
    [Abstract] [Full Text] [Related]

  • 7. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
    Rapoport AM, Freitag F, Pearlman SH.
    CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065
    [Abstract] [Full Text] [Related]

  • 8. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Goldstein J, Smith TR, Pugach N, Griesser J, Sebree T, Pierce M.
    Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
    [Abstract] [Full Text] [Related]

  • 9. Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.
    Garnock-Jones KP.
    Drugs; 2013 Sep; 73(13):1483-90. PubMed ID: 23912626
    [Abstract] [Full Text] [Related]

  • 10. A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
    Gutman D, Hellriegel E, Aycardi E, Bigal ME, Kunta J, Chitra R, Kansagra S, Kidron OS, Knebel H, Linder S, Ma Y, Pierce M, Winner PK, Spiegelstein O.
    Headache; 2016 Sep; 56(8):1300-9. PubMed ID: 27474357
    [Abstract] [Full Text] [Related]

  • 11. Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial.
    Bigal ME, Lipton RB, Newman LC, Pierce MW, Silberstein SD.
    Headache; 2015 Sep; 55(8):1124-32. PubMed ID: 26178815
    [Abstract] [Full Text] [Related]

  • 12. Sumatriptan iontophoretic transdermal system: A novel approach to migraine-specific therapy.
    Goldstein J.
    Neurol Clin Pract; 2014 Oct; 4(5):454-457. PubMed ID: 29443222
    [Abstract] [Full Text] [Related]

  • 13. Sumatriptan iontophoretic patch for migraine.
    Tepper DE.
    Headache; 2014 Oct; 54(9):1563-4. PubMed ID: 25324166
    [No Abstract] [Full Text] [Related]

  • 14. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
    Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ.
    Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
    [Abstract] [Full Text] [Related]

  • 15. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH, Tepper SJ, Wein T, Schweizer E, Ramos E.
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [Abstract] [Full Text] [Related]

  • 16. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 17. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
    Cady RK, Aurora SK, Brandes JL, Rothrock JF, Myers JA, Fox AW, Farr SJ.
    Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
    [Abstract] [Full Text] [Related]

  • 18. A sumatriptan patch (Zecuity) for migraine.
    Med Lett Drugs Ther; 2015 Nov 09; 57(1481):151-2. PubMed ID: 26529132
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S, Heidari K, Vafaee R, Forouzanfar MM, Amini A, Shahrami A.
    Headache; 2014 Jan 09; 54(1):94-108. PubMed ID: 24182419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.